AbbVie Inc.
ABBV · NYSE
Earnings history and estimates
Reported and estimated revenue, EPS and post-earnings movement.
| Period | Date | Revenue actual | Revenue estimate | EPS actual | EPS estimate | 1D move |
|---|---|---|---|---|---|---|
| 2026 Q2 | July 31, 2026 | — | 16.78B | — | 3.66 | — |
| 2026 Q1 | April 29, 2026 | 15.00B | 14.72B | 0.39 | 2.62 | +3.14% |
| 2025 Q4 | February 4, 2026 | 16.62B | 16.41B | 2.71 | 2.66 | -3.79% |
| 2025 Q3 | October 31, 2025 | 15.78B | 15.59B | 1.86 | 1.77 | -4.45% |
| 2025 Q2 | July 31, 2025 | 15.42B | 15.03B | 2.97 | 2.89 | -0.15% |
| 2025 Q1 | April 25, 2025 | 13.34B | 12.93B | 2.46 | 2.39 | +3.15% |
| 2024 Q4 | January 31, 2025 | 15.10B | 14.83B | 2.16 | 2.13 | +4.70% |
| 2024 Q3 | October 30, 2024 | 14.46B | 14.28B | 3.00 | 2.92 | +6.36% |
| 2024 Q2 | July 25, 2024 | 14.46B | 14.02B | 2.65 | 2.57 | +3.38% |
| 2024 Q1 | April 26, 2024 | 12.31B | 11.93B | 2.31 | 2.26 | -4.58% |
| 2023 Q4 | February 2, 2024 | 14.30B | 12.98B | 2.79 | 2.76 | +0.64% |
| 2023 Q3 | October 27, 2023 | 13.93B | 13.67B | 2.95 | 2.86 | -4.32% |
| 2023 Q2 | July 27, 2023 | 13.87B | 13.52B | 2.91 | 2.81 | +4.90% |
| 2023 Q1 | April 27, 2023 | 12.23B | 12.17B | 2.46 | 2.44 | -7.99% |
| 2022 Q4 | February 9, 2023 | 15.12B | 15.33B | 3.60 | 3.54 | +2.83% |
| 2022 Q3 | October 28, 2022 | 14.81B | 14.96B | 3.66 | 3.56 | -3.84% |